On June 21-23, 2011, the New York Academy of Sciences will bring together physicians, neurologists, clinical neuropsychologists, cellular and molecular biologists and patient advocates to discuss current challenges and potential solutions for improving diagnosis, treatment and management of the cognitive symptoms of MS.
This two-and-a-half day conference titled "Cognitive Dysfunction in Multiple Sclerosis: New Approaches to Diagnosis and Treatment" will include four sessions covering: I) how lesions in the brain are responsible for cognitive impairment in MS; II) novel drug therapies that may improve cognitive symptoms of the disease; III) new tests designed to diagnose cognitive impairment in patients; and IV) how brain imaging can help us better understand cognitive dysfunction in MS.
The conference will begin with a public lecture by Dr Aaron Miller of Mount Sinai Medical Center titled "State of the Science in Therapeutics for Multiple Sclerosis." This lecture will be followed by a panel discussion featuring patient advocates Cynthia Sitcov and Jeffrey Gingold, and Dr Nicholas LaRocca of the National Multiple Sclerosis Society. A reception and book signing will follow. Registration is required.
"The therapeutic advances have been remarkable since first learning I had MS in 1975. For anyone who lives with MS or knows someone who does, this lecture will provide an opportunity to learn about the newest treatments and get input from MS patient advocates," says Cynthia Sitcov, Patient's Representative, Central and Peripheral System Advisory Committee, US Food and Drug Administration.
Rethinking the germ theory: A balanced take on microbes and disease outcomes